A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk.
from NYT > Health http://ift.tt/2fdk4LS
via health&fitness
Aucun commentaire:
Enregistrer un commentaire